Creative Biosciences (Guangzhou) Co., Ltd.
With its headquarter located in high-tech development zone in Guangzhou including R&D lab, GMP plant and spacious integrated office area, covering 16,000 total square meters, CreativeBio possesses four testing labs scattered in Guangzhou, Tianjin, Wuhan and Jinan. The research and development capacity and the whole team potential have been enhanced after the acquisition of Helixgen in March, 2020. The company not only occupies independent intellectual property rights but also boasts its world leading research and development team, with which more are expected in the future and will be transformed into productivity. On top of Colosafe®, other early detection test kits for lung, bladder, cervical and liver cancers and POCT products are in development and has achieved surprising advancement.
CreativeBio has completed several rounds of venture capital fundraising by far and won tremendous support from all levels of nation, province, municipality and district respectively. Evidently it has emerged as a notable star in the industry. Guided by the ultimate goal of "Human Health, Our Mission", CreativeBio is striving to make breakthroughs in early diagnosis, early intervention and prognosis monitoring of chronicle diseases specifically in cancer to benefit all nations.